ALPS Medical Breakthroughs ETF (SBIO)
- Previous Close
31.53 - Open
31.62 - Bid 31.51 x 1800
- Ask 32.82 x 1800
- Day's Range
31.70 - 32.16 - 52 Week Range
23.21 - 38.80 - Volume
3,934 - Avg. Volume
13,741 - Net Assets 115.56M
- NAV 31.48
- PE Ratio (TTM) --
- Yield 0.20%
- YTD Daily Total Return -4.28%
- Beta (5Y Monthly) 0.83
- Expense Ratio (net) 0.50%
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
ALPS
Fund Family
Health
Fund Category
115.56M
Net Assets
2014-12-30
Inception Date
Performance Overview: SBIO
Trailing returns as of 4/25/2024. Category is Health.
People Also Watch
Holdings: SBIO
Top 10 Holdings (31.42% of Total Assets)
Sector Weightings
Recent News: SBIO
Research Reports: SBIO
Analyst Report: Fanuc Corporation
Fanuc's primary products include industrial robots, computerized numerical control systems, and compact machining centers (Robodrills) globally. The company had its beginnings as part of Fujitsu developing early numerical control systems and commands the top global market share with its CNC systems and industrial robots.
RatingPrice TargetAnalyst Report: Netflix, Inc.
Netflix’s relatively simple business model involves only one business, its streaming service. It has the biggest television entertainment subscriber base in both the United States and the collective international market, with almost 250 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm recently began introducing ad-supported subscription plans, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.
RatingPrice TargetAnalyst Report: Netflix, Inc.
Netflix’s relatively simple business model involves only one business, its streaming service. It has the biggest television entertainment subscriber base in both the United States and the collective international market, with almost 250 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm recently began introducing ad-supported subscription plans, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.
RatingPrice TargetAnalyst Report: Alibaba Group Holding Limited
Alibaba is the world’s largest online and mobile commerce company as measured by gross merchandise volume. It operates China’s online marketplaces, including Taobao (consumer-to-consumer) and Tmall (business-to-consumer). The China commerce retail division is the most valuable cash-flow-generating business at Alibaba. Additional revenue sources include China commerce wholesale, international commerce retail/wholesale, local consumer services, cloud computing, digital media and entertainment platforms, Cainiao logistics services, and innovation initiatives/other.
RatingPrice Target